Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Dec 18 2025

Full Issue

Research Roundup: The Latest Science, Discoveries, And Breakthroughs

Each week, KFF Health News compiles a selection of health policy studies and briefs.

CIDRAP: COVID Lockdowns May Have Slowed Toddler Development, While Reopenings Tied To Better Mental Health In Older Kids 

A pair of analyses on the effects of COVID-related public health measures on children ties lockdowns and physical distancing to developmental delays among toddlers in Scotland and school reopenings to improved mental health in California students. (Van Beusekom, 12/16)

CIDRAP: RSV Vaccine Protects Older Adults, And Drug Protects Babies, But Less So Over Time, Studies Suggest 

Two studies on respiratory syncytial virus (RSV) protection conclude that vaccine effectiveness against infection and related health care use drops over 18 months in US veterans and that the effectiveness of the long-acting monoclonal antibody preventive nirsevimab is strong in hospitalized European children younger than two years but wanes over seven months. Older adults and infants are especially vulnerable to severe RSV, with possible complications of bronchiolitis, pneumonia, and sepsis. (Van Beusekom, 12/17)

MedPage Today: Combination Model May Improve Diagnosis Of Serious Respiratory Infections 

Pairing a biomarker with AI analysis could also help cut unnecessary antibiotic use. (Rudd, 12/17)

MedPage Today: Two Extended-Release Buprenorphine Doses Effective In High-Risk Opioid Use Disorder 

Maintenance with higher monthly dose level may provide an advantage in heavy fentanyl users. (Jeffrey, 12/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF